Physician

Charles L Ludivico, MD

According to 2025 Medicare claims, Charles Ludivico, MD (NPI: 1750439147) practices rheumatology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Northampton, PA. This provider's primary affiliated billing organization is EAST PENN RHEUMATOLOGY ASSOCIATES, P.C. (NPI: 1346388998; TIN: 232681931) and primary practice location at 18015-1153.

Ludivico's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 336 traditional Medicare patients, billed 16,741 HCPCS/CPT codes, and received $415,716 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,066 prescription claims across 408 beneficiaries totaling $2,740,964 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 74 records totaling $8,973. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $189,685 to $415,716. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,153,707 to $2,740,964. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$216K$432K2015 Medicare payment: $189,685 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $164,612 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $166,153 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $213,976 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $253,577 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $391,953 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $431,870 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $346,495 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $385,961 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $415,716 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157976,649$189,685
20167375,273$164,612
20177025,884$166,153
20187068,303$213,976
201961210,068$253,577
202050114,104$391,953
202149114,605$431,870
202241211,647$346,495
202338616,464$385,961
202433616,741$415,716

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2015 Drug cost: $1,153,707 (USD; Tot_Drug_Cst)2016 Drug cost: $891,789 (USD; Tot_Drug_Cst)2017 Drug cost: $1,163,837 (USD; Tot_Drug_Cst)2018 Drug cost: $1,146,967 (USD; Tot_Drug_Cst)2019 Drug cost: $811,385 (USD; Tot_Drug_Cst)2020 Drug cost: $1,479,283 (USD; Tot_Drug_Cst)2021 Drug cost: $2,283,451 (USD; Tot_Drug_Cst)2022 Drug cost: $2,563,939 (USD; Tot_Drug_Cst)2023 Drug cost: $2,505,293 (USD; Tot_Drug_Cst)2024 Drug cost: $2,740,964 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155153,010$1,153,707
20165062,960$891,789
20174792,853$1,163,837
20184632,634$1,146,967
20194132,318$811,385
20204663,065$1,479,283
20214933,816$2,283,451
20224443,567$2,563,939
20234363,337$2,505,293
20244083,066$2,740,964

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more4257$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more317627$87
J0897Injection, denosumab, 1 mg434,800$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's245507$12
96372Injection of drug or substance under skin or into muscle4489$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab842,800$905,925
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5020272$399,766
Enbrel SureclickEtanercept23812$209,746
XeljanzTofacitinib Citrate341,200$174,786
Xeljanz XrTofacitinib Citrate23810$150,372

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$1,257ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.2$7,716Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles L. Ludivico, MD?

Tedicare shows public-source Medicare data for Charles L. Ludivico, MD (NPI 1750439147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles L. Ludivico, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles L. Ludivico, MD?

Charles L. Ludivico, MD is linked to EAST PENN RHEUMATOLOGY ASSOCIATES, P.C. (billing NPI 1346388998) in the available physician profile data.

Does Charles L. Ludivico, MD have Open Payments data?

Charles L. Ludivico, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.